TheraNova Nordic ApS: Financial statements 2023
CVR: 39346788
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
TheraNova Nordic ApS (CVR 39346788) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 21,171 and a net result of DKK 14,729 compared with DKK -446,249 the year before. Equity in the 2023 report amounted to DKK 35,730. The solvency ratio was 9.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 21,171
- Profit/Loss
- DKK 14,729
- Equity
- DKK 35,730
- Total Assets
- DKK 369,906
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 21 t. | 15 t. | 36 t. | 1 |
| 2022 | - | -565 t. | -446 t. | 21 t. | 1 |
| 2021 | - | 274 t. | 222 t. | 467 t. | 1 |
| 2020 | - | 442 t. | 253 t. | 245 t. | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout TheraNova Nordic ApS
TheraNova Nordic ApS is a Danish company of the type Anpartsselskab based in Fredericia, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Terapishop DK ApS. The management consists of Gitte Anna Lasota. The company is owned by LASOTA HOLDING ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -8,001 and a net result of DKK 5,358 compared with DKK -70,464 the year before. Equity in the 2025 report amounted to DKK -29,376.